2023 Cannabis Year in Review and 2024 Outlook

2023 Cannabis Year in Review and 2024 Outlook
Blunt Business
Enjoy this episode?
Subscribe to Blunt Business for new episodes.

2023 Cannabis Year in Review and 2024 Outlook
Blunt Business
Enjoy this episode?
Subscribe to Blunt Business for new episodes.
This episode of Blunt Business explores a significant shift in federal drug policy following a new executive order aimed at accelerating research into psychedelics like LSD, psilocybin, and ibogaine for treating mental health disorders.